BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response

Therapeutic strategies aiming to leverage anti-tumor immunity are being intensively investigated as they show promising results in cancer therapy. The PD-1/PD-L1 pathway constitutes an important target to restore functional anti-tumor immune response. Here, we report that BET protein inhibition supp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Lett
Hlavní autoři: Andrieu, Guillaume P., Shafran, Jordan S., Smith, Charlotte L., Belkina, Anna C., Casey, Allison N., Jafari, Naser, Denis, Gerald V.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6901183/
https://ncbi.nlm.nih.gov/pubmed/31473251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2019.08.013
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky